Patents by Inventor George D. Hartman

George D. Hartman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives And Methods Of Treating Hepatitis B Infections
    Publication number: 20190031653
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: July 2, 2018
    Publication date: January 31, 2019
    Inventors: George D. Hartman, Scott Kuduk
  • Derivatives and methods of treating hepatitis B infections
    Patent number: 10189835
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: January 29, 2019
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
    Publication number: 20190016682
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: December 22, 2017
    Publication date: January 17, 2019
    Inventors: George D. Hartman, Scott Kuduk
  • Derivatives and methods of treating hepatitis B infections
    Patent number: 10093669
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: October 9, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Crystalline forms of a hepatitis B antiviral agent
    Patent number: 10077239
    Abstract: This disclosure provides crystalline forms of a hepatitis B antiviral agent, and methods of making and using these forms.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: September 18, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventor: George D. Hartman
  • Derivatives and methods of treating hepatitis B infections
    Patent number: 10077264
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: September 18, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • AZOCANE AND AZONANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
    Publication number: 20180201590
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: December 20, 2017
    Publication date: July 19, 2018
    Inventors: George D. Hartman, Scott Kuduk
  • DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
    Publication number: 20180127415
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: December 15, 2017
    Publication date: May 10, 2018
    Inventors: George D. Hartman, Scott Kuduk
  • AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
    Publication number: 20180044300
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: August 8, 2017
    Publication date: February 15, 2018
    Inventor: George D. Hartman
  • Derivatives and methods of treating hepatitis B infections
    Patent number: 9890161
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: February 13, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Azocane and azonane derivatives and methods of treating hepatitis B infections
    Patent number: 9884831
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: February 6, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9873671
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: January 23, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • HEPATITIS B ANTIVIRAL AGENTS
    Publication number: 20170334882
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Application
    Filed: June 2, 2017
    Publication date: November 23, 2017
    Inventors: George D. Hartman, Osvaldo A. Flores
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9758489
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: September 12, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventor: George D. Hartman
  • Hepatitis B antiviral agents
    Patent number: 9751857
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: September 5, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Osvaldo A. Flores
  • COMBINATION THERAPY FOR TREATMENT OF HBV INFECTIONS
    Publication number: 20170182021
    Abstract: Provided herein is a combination therapy comprising a compound of Formula I and peginterferon alfa-2a, or another interferon analog. The combination therapy is useful for the treatment of HBV infection. Also provided herein are compositions comprising a compound of Formula I and peginterferon alfa-2a, or another interferon analog.
    Type: Application
    Filed: October 4, 2016
    Publication date: June 29, 2017
    Inventor: George D. Hartman
  • Hepatitis B antiviral agents
    Patent number: 9676747
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: June 13, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Osvaldo A. Flores
  • Derivatives And Methods Of Treating Hepatitis B Infections
    Publication number: 20170158691
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: December 12, 2016
    Publication date: June 8, 2017
    Inventors: George D. Hartman, Scott Kuduk
  • DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
    Publication number: 20170121328
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: November 9, 2016
    Publication date: May 4, 2017
    Inventors: George D. Hartman, Scott Kuduk
  • DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
    Publication number: 20170121329
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: November 15, 2016
    Publication date: May 4, 2017
    Inventors: George D. Hartman, Scott Kuduk